Related Experiment Video

Updated: May 26, 2025

An HS-MRM Assay for the Quantification of Host-cell Proteins in Protein Biopharmaceuticals by Liquid Chromatography Ion Mobility QTOF Mass Spectrometry
11:09

An HS-MRM Assay for the Quantification of Host-cell Proteins in Protein Biopharmaceuticals by Liquid Chromatography Ion Mobility QTOF Mass Spectrometry

Published on: April 17, 2018

10.0K

Bioanalytical Assays for Oligonucleotide Therapeutics: Adding Antibody-Based Immunoassays to the Toolbox as an

David P Chimento1, Amy L Anderson1, Inês Fial2

  • 1Rockland Immunochemicals Inc., Limerick, Pennsylvania, USA.

Nucleic Acid Therapeutics
|February 24, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
analytical assaysantibody-based assayslocalizationoligonucleotide therapeuticsquantification

More Related Videos

Microfluidic On-chip Capture-cycloaddition Reaction to Reversibly Immobilize Small Molecules or Multi-component Structures for Biosensor Applications
14:43

Microfluidic On-chip Capture-cycloaddition Reaction to Reversibly Immobilize Small Molecules or Multi-component Structures for Biosensor Applications

Published on: September 23, 2013

10.8K
Label-Free Immunoprecipitation Mass Spectrometry Workflow for Large-scale Nuclear Interactome Profiling
11:19

Label-Free Immunoprecipitation Mass Spectrometry Workflow for Large-scale Nuclear Interactome Profiling

Published on: November 17, 2019

16.0K

Related Experiment Videos

Last Updated: May 26, 2025

An HS-MRM Assay for the Quantification of Host-cell Proteins in Protein Biopharmaceuticals by Liquid Chromatography Ion Mobility QTOF Mass Spectrometry
11:09

An HS-MRM Assay for the Quantification of Host-cell Proteins in Protein Biopharmaceuticals by Liquid Chromatography Ion Mobility QTOF Mass Spectrometry

Published on: April 17, 2018

10.0K
Microfluidic On-chip Capture-cycloaddition Reaction to Reversibly Immobilize Small Molecules or Multi-component Structures for Biosensor Applications
14:43

Microfluidic On-chip Capture-cycloaddition Reaction to Reversibly Immobilize Small Molecules or Multi-component Structures for Biosensor Applications

Published on: September 23, 2013

10.8K
Label-Free Immunoprecipitation Mass Spectrometry Workflow for Large-scale Nuclear Interactome Profiling
11:19

Label-Free Immunoprecipitation Mass Spectrometry Workflow for Large-scale Nuclear Interactome Profiling

Published on: November 17, 2019

16.0K

Related Concept Videos

Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

12.4K
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or...
12.4K

Articles linked to this work by shared authors, journal, and citation graph.

Investigating the Biophysical Properties and In Vivo Activity of 7',5'-Alpha-Bicyclo-DNA Phosphodiester Backbone Gapmer Antisense Oligonucleotides.

Nucleic acid therapeutics·2026

Characterizing Antibodies Targeting Antisense Oligonucleotide Phosphorothioate and 2'-O-Methoxyethyl Modifications for Intracellular Trafficking and Biodistribution Studies.

Nucleic acid therapeutics·2025

Mettl3-catalyzed m6A regulates histone modifier and modification expression in self-renewing somatic tissue.

Science advances·2023

MLL4 mediates differentiation and tumor suppression through ferroptosis.

Science advances·2021

Nonclinical Development of Oligonucleotide-Based Therapeutics: Insights from an IQ DruSafe ONT Working Group Survey.

Nucleic acid therapeutics·2026

Incorporation of a pH-Sensitive Linker into Lipid-ASO Conjugates Drives Increased Endosomal Membrane Remodeling Events.

Nucleic acid therapeutics·2026

rHuPH20 Enhances Extravascular Delivery of mRNA Lipid Nanoparticles in Mice and Minipigs.

Nucleic acid therapeutics·2026

Embryo-Fetal Development and Maternal-Fetal Exposure of the Von Willebrand Factor Binding Aptamer Rondaptivon Pegol (BT200) in Rabbits.

Nucleic acid therapeutics·2026

Evaluation of Antisense Oligonucleotide-Associated Neuronal Lysosomal Changes.

Nucleic acid therapeutics·2026

Biodistribution of Phosphorothioate-Based Antisense Oligonucleotides in Stabilin Receptor Knock-Out Models.

Nucleic acid therapeutics·2026

Targeting UAP1 with rabeprazole: a novel repurposed therapeutic strategy for multiple myeloma.

Frontiers in pharmacology·2026

Combined RNA- and DNA-targeting CRISPR ribonucleoproteins enhance suppression of HBV transcripts.

Frontiers in genome editing·2026

Serum MMP-3/TIMP-1 ratio is a potential diagnostic marker for HIV-associated neurocognitive disorders.

Research square·2026

'An NF2- wildtype malignant meningioma cell line for basic and translational science'.

bioRxiv : the preprint server for biology·2026

APOBEC3G Splicing Defects in Nonhuman Primate Models Result in Disparate Viral Mutational Profiles Relative to Humans.

bioRxiv : the preprint server for biology·2026

AnchorR: A QuPath and R interface for collaborative exploration of spatial transcriptomics and histology.

bioRxiv : the preprint server for biology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us